{"gene":"EFNB2","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1995,"finding":"EFNB2 (LERK-5) was identified as a membrane-bound ligand for both ELK and HEK (EPH-related receptor tyrosine kinases) and induces receptor phosphorylation upon binding.","method":"cDNA isolation, receptor binding assay, receptor phosphorylation assay in vitro","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct receptor phosphorylation assay with identified binding partners, single lab but two orthogonal methods (binding + phosphorylation)","pmids":["8559144"],"is_preprint":false},{"year":2011,"finding":"T cell-specific double knockout of Efnb1 and Efnb2 in mice compromised IL-6 signaling, specifically abolishing STAT3 phosphorylation upon IL-6 stimulation, contributing to defects in Th1/Th17 differentiation and antiviral immune response.","method":"Conditional knockout mice (loxP-mediated), flow cytometry, in vitro T cell differentiation assays, STAT3 phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean conditional KO with defined cellular phenotype and biochemical pathway readout (STAT3 phosphorylation), single lab","pmids":["21976681"],"is_preprint":false},{"year":2012,"finding":"T cell-specific single knockout of EFNB2 alone causes a moderate increase in DN3 thymocyte subpopulation and CD4CD8 double-negative cells, but does not broadly impair T cell activation, proliferation, or Th1/Th2/Th17/Treg differentiation, indicating functional redundancy within the Eph/ephrin family.","method":"Conditional knockout mice, flow cytometry, competitive repopulation chimeras, in vitro T cell differentiation and activation assays","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean conditional KO with multiple cellular readouts, single lab","pmids":["22673212"],"is_preprint":false},{"year":2015,"finding":"In T cells, deletion of the intracellular tails of Efnb1 and Efnb2 revealed critical regions controlling T cell chemotaxis toward CXCL12; Efnb1/Efnb2-deficient T cells showed reduced migration to arthritic paws in vivo and impaired chemotaxis in vitro, and provided inferior B cell help for collagen-specific antibody production.","method":"Conditional double knockout mice (CIA model), deletion mutagenesis of intracellular tail, in vitro chemotaxis assay, in vivo migration assay, B cell help assay","journal":"Arthritis & rheumatology (Hoboken, N.J.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion mutagenesis combined with in vivo and in vitro functional assays, single lab","pmids":["25779027"],"is_preprint":false},{"year":2016,"finding":"Smooth muscle cell-specific deletion of EFNB2 in male mice reduced blood pressure. Both forward (EFNB2-to-EPH) and reverse (EPH-to-EFNB2) signaling regulate vascular smooth muscle cell contractility; EPHB4 was identified as the critical receptor for forward signaling by crosslinking studies, and a region from aa 313 to aa 331 in the EFNB2 intracellular tail was essential for reverse signaling regulating VSMC contractility.","method":"Smooth muscle cell-specific conditional knockout mice, blood pressure measurement, crosslinking studies, intracellular tail deletion mutagenesis, VSMC contractility assays","journal":"European journal of human genetics : EJHG","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — conditional KO, crosslinking to identify receptor, deletion mutagenesis to map functional domain, multiple orthogonal methods in one study","pmids":["27530629"],"is_preprint":false},{"year":2008,"finding":"In mouse endometrium, uNK cells express EFNB2 early in gestation then transition to EPHB4 expression; spiral arteries shift from EFNB2+/EPHB4- to EFNB2+/EPHB4+, and expression of EFNB2 by uNK cells and trophoblasts is proposed as the mechanism driving their positional association with EFNB2+ arteries and exclusion from EPHB4+ veins. Gain of EPHB4 by midgestation spiral arteries may signal completion of arterial modification.","method":"Immunohistochemistry time-course in normal and uNK cell-deficient (alymphoid) mice, lymphocyte transfer rescue experiments","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by IHC with functional consequence assessed by genetic (alymphoid) model and rescue, single lab","pmids":["18463357"],"is_preprint":false},{"year":2015,"finding":"In zebrafish, genetic interaction studies showed that sox7 acts upstream of Notch (with hey2 and efnb2) in arterial specification; loss of sox7, hey2, or efnb2 each produce similar aberrant arteriovenous shunts, and overexpression of Notch intracellular domain rescues the sox7 mutant phenotype, placing sox7 upstream of Notch/hey2/efnb2 in arterial development.","method":"Zebrafish mutant generation, in vivo imaging, genetic epistasis (NICD overexpression rescue), in situ hybridization, transgenic reporter lines","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with rescue experiment, multiple mutants and orthogonal methods, single lab","pmids":["25834021"],"is_preprint":false},{"year":2016,"finding":"NOTCH4 (not NOTCH1) is the specific receptor for the DLL4/NOTCH-EFNB2 cascade in endothelial progenitor cells; NOTCH4 downregulation decreased EFNB2 expression, while NOTCH1 silencing increased EFNB2 expression, demonstrating that NOTCH4 positively regulates EFNB2 expression in this context.","method":"siRNA knockdown of NOTCH4 vs NOTCH1 in EPCs, DLL4 stimulation, western blot, functional EPC assays","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — comparative knockdown of two receptors with biochemical and functional readouts, single lab","pmids":["27069008"],"is_preprint":false},{"year":2020,"finding":"Trans-interaction between EphB4 and EFNB2 mediates bi-directional signaling: forward EFNB2-to-EphB4 signaling suppresses tumor cell proliferation, while reverse EphB4-to-EFNB2 signaling stimulates invasive and angiogenic properties of endothelial cells; a dual-function agonist peptide (BIDEN-AP) that engages EphB4 suppressed invasion, EMT, and endothelial migration in vitro and reduced orthotopic tumor growth in vivo.","method":"Peptide agonist design, in vitro invasion/migration/tube formation assays, in vivo orthotopic tumor model, receptor-mediated endocytosis assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vitro and in vivo functional assays demonstrating bi-directional signaling, single lab","pmids":["31949258"],"is_preprint":false},{"year":2020,"finding":"Knockdown of EFNB2 in pancreatic ductal adenocarcinoma cells inhibited cell proliferation by upregulating p53/p21-mediated G0/G1 phase cell cycle arrest, and decreased migration and invasion by blocking epithelial-mesenchymal transition.","method":"siRNA knockdown in PDAC cell lines, cell cycle analysis, in vitro migration/invasion assays, western blot, in vivo xenograft","journal":"Biomedicine & pharmacotherapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined molecular pathway (p53/p21) and multiple cellular phenotype readouts, single lab","pmids":["32036221"],"is_preprint":false},{"year":2021,"finding":"Ephrin-B2 promotes assembly of connexin 30 (Cx30) gap junction plaques between cochlear Deiters' cells; in situ proximity ligation assay showed ephrin-B2 preferentially interacts with Cx30 at the periphery of gap junction plaques. Efnb2 haploinsufficiency causes excessive clathrin-mediated internalization of Cx30 plaques in early postnatal stages. Ectopic activation of ephrin-B2 reverse signaling promotes Cx30 gap junction plaque internalization, suggesting a cell-autonomous, Eph receptor-independent role.","method":"In situ proximity ligation assay, heterozygous Efnb2 null mice, clathrin internalization assay, in vitro organotypic assay with ephrin-B2 reverse signaling activation","journal":"Brain research bulletin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proximity ligation assay identifies Cx30 interaction, haploinsufficiency model with in vitro organotypic validation, single lab","pmids":["34139316"],"is_preprint":false},{"year":2022,"finding":"NKX2-1 directly represses Efnb2 transcription in tracheal cells (demonstrated by chromatin immunoprecipitation and reporter assays); Efnb2 regulates tracheoesophageal separation by controlling dorsoventral allocation of tracheal-fated cells, and ectopic NKX2-1/EPHRIN-B2 boundaries organize ectopic tracheal separation via cell sorting.","method":"Conditional knockout mice, chromatin immunoprecipitation (ChIP), reporter assays, lineage tracing, mosaic NKX2-1 loss-of-function","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP and reporter assays establish direct transcriptional repression; lineage tracing and genetic mosaic provide mechanistic pathway placement; multiple orthogonal methods","pmids":["35294885"],"is_preprint":false},{"year":2022,"finding":"The EFNB2/EPHB4 axis in colorectal cancer liver metastases promotes LDLR-mediated cholesterol uptake by activating STAT3 phosphorylation, which enhances LDLR transcription; blocking LDLR reversed the tumor-promoting role of the EFNB2/EPHB4 axis.","method":"In vitro cell line studies, in vivo mouse model, STAT3 phosphorylation assay, LDLR transcription assay, blocking experiments","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissection with rescue (LDLR blocking), multiple in vitro and in vivo methods, single lab","pmids":["36376513"],"is_preprint":false},{"year":2022,"finding":"ITGA5 (integrin subunit alpha 5), acting as a downstream effector of mTORC1, promotes laryngeal squamous cell carcinoma progression through upregulation of EFNB2, defining an mTORC1-ITGA5-EFNB2 signaling axis.","method":"Stable Raptor knockdown, transcriptomic sequencing, western blot, immunofluorescence, xenograft models (CDX and PDX)","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway established using stable KD of upstream component, multiple orthogonal methods, single lab","pmids":["36438491"],"is_preprint":false},{"year":2015,"finding":"EFNB2 expression in MDCK cells (which have low RSV susceptibility) increased RSV replication 10-100 fold; siRNA knockdown of EFNB2 in RSV-susceptible cell lines (HEp-2 and A549) reduced RSV replication, establishing EFNB2 as a positive host factor for RSV replication.","method":"cDNA library transfection into MDCK cells, microarray analysis, siRNA knockdown, viral replication assays","journal":"Virus research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function and loss-of-function experiments in multiple cell lines converge on same conclusion, single lab","pmids":["26277777"],"is_preprint":false},{"year":2024,"finding":"EFNB2 overexpression in nucleus pulposus cells activated the PI3K/AKT signaling pathway (increased phosphorylation of PI3K, AKT, and mTOR) and inhibited ERK1/2 phosphorylation, thereby reducing apoptosis; these anti-apoptotic effects were partially reversed by PI3K inhibitor LY294002 and ERK activator Ceramide C6 respectively.","method":"EFNB2 overexpression and knockdown in NP cells, PI3K inhibitor (LY294002) and ERK activator treatment, western blot for pathway components, apoptosis assays","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissection with pharmacological inhibitors confirming PI3K/AKT and ERK mechanisms, single lab","pmids":["38636690"],"is_preprint":false},{"year":2024,"finding":"Endothelial cell-specific conditional knockout of Efnb2 in adult mice delayed capillary regeneration after acute skeletal muscle injury (reduced capillary area at 5 days post-injury) and attenuated recovery of neuromuscular junction structure and function (neuromuscular transmission failure with perturbed pre- and postsynaptic NMJ morphology).","method":"Inducible endothelial cell-specific conditional knockout (tamoxifen), BaCl2 muscle injury model, intravascular staining, isometric force measurement, nerve vs. direct stimulation, NMJ morphology analysis","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible cell-type-specific KO with multiple orthogonal functional readouts (capillary area, isometric force, NMJ morphology, neuromuscular transmission), rigorous controls","pmids":["39196901"],"is_preprint":false},{"year":2016,"finding":"miR-137 directly targets the 3'-UTR of EFNB2 mRNA and suppresses EFNB2 expression; a genetic variant SNP rs550067317 in the putative seed-pair region of the EFNB2 3'-UTR reverses the repressive effect of miR-137 on EFNB2.","method":"Luciferase reporter assays with wild-type and point-mutant 3'-UTR constructs, RT-qPCR, western blot","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter with mutagenesis establishes direct miR-137 targeting of EFNB2 3'-UTR, supported by expression assays, single lab","pmids":["27650867"],"is_preprint":false},{"year":2024,"finding":"In zebrafish and Caco-2 spheroid cultures, EFNB2 is compartmentalized to the basolateral domain of epithelial cells; EFNB2 is required for epithelial morphogenesis (spheroid organization) acting through its cognate receptor EPHB4, which randomizes mitotic spindle orientation when depleted. EFNB2 is the most abundantly expressed EPHB4 ligand in Caco-2 cells.","method":"siRNA/shRNA depletion in Caco-2 spheroids, immunofluorescence localization, mitotic spindle orientation analysis, receptor ligand expression profiling","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, depletion phenotype with localization data but limited mechanistic detail on EFNB2-specific contribution vs EPHB4","pmids":["bio_10.1101_2024.07.15.603563"],"is_preprint":true},{"year":2021,"finding":"miR-193a-3p directly targets EFNB2 (confirmed by luciferase activity assay); miR-193a-3p-mediated suppression of EFNB2 promotes EMT (increased N-cadherin, vimentin, MMP2, MMP9; decreased E-cadherin) and enhances trophoblast cell migration and invasion, contributing to placenta accreta spectrum.","method":"Luciferase reporter assay, miR-193a-3p overexpression/inhibition, siEFNB2, Transwell migration/invasion assay, western blot for EMT markers","journal":"Frontiers in molecular biosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct target validation by luciferase assay plus functional rescue experiments, single lab","pmids":["33585562"],"is_preprint":false},{"year":2018,"finding":"Exogenous EFNB2 supplementation stimulated pulmonary branching in fetal rat lung explants and decreased the activity of p38, JNK, ERK, and STAT signaling pathways in the context of congenital diaphragmatic hernia.","method":"Ex vivo fetal lung culture, EFNB2 protein supplementation, Western blot for signaling pathways, morphometric analysis of branching","journal":"International journal of molecular medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single treatment assay in explant culture, single lab, no mutagenesis or receptor identification","pmids":["30106123"],"is_preprint":false},{"year":2024,"finding":"TAMs expressing EFNB2 interact with gastric cancer tumor cells expressing EPHB2 via forward downstream signaling, leading to circadian rhythm disorder (CRD) in tumor cells and enhancement of the Warburg effect in metastatic liver niches.","method":"Co-culture experiments, 3D cell culture, intrasplenic injection in vivo model, clodronate macrophage depletion, bone marrow transplantation, EPH inhibitor treatment, PDX model","journal":"Cellular oncology (Dordrecht, Netherlands)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vivo and in vitro methods identifying EFNB2-EPHB2 forward signaling as the mechanistic axis, single lab","pmids":["39298082"],"is_preprint":false},{"year":2024,"finding":"In a preclinical HNSCC model, vascular EFNB2 knockout combined with radiation therapy enhanced anti-tumor immunity, reduced Treg accumulation, and decreased metastasis; EFNB2-Fc fusion protein targeting the EphB4-ephrinB2 axis reduced local tumor growth and distant metastasis.","method":"Vascular-specific EFNB2 knockout mouse model, radiation therapy combination, tumor microenvironment immune profiling, EFNB2-Fc and Fc-TNYL-RAW-GS peptide treatment, preclinical HNSCC models","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, functional phenotype in vascular-specific KO but limited biochemical mechanism for EFNB2 specifically","pmids":["bio_10.1101_2024.07.21.604518"],"is_preprint":true},{"year":2025,"finding":"Reactivation of the EFNB2 pathway by exogenous EFNB2 recombinant protein rescued dendritic outgrowth deficits in Zmiz1 mutant cortical neurons, placing EFNB2 as a downstream effector of the transcriptional regulator ZMIZ1 in cortical neuron development.","method":"Zmiz1 forebrain-specific conditional knockout mice, transcriptomic analysis, exogenous EFNB2 recombinant protein rescue experiment, dendritic morphology quantification","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, rescue experiment with recombinant protein, single lab, pathway placement inferred from transcriptomics + single rescue assay","pmids":["bio_10.1101_2024.08.18.608498"],"is_preprint":true}],"current_model":"EFNB2 (ephrin-B2) is a membrane-bound ligand for EPH receptor tyrosine kinases (particularly EPHB4) that mediates bi-directional signaling: forward signaling (EFNB2-to-EphB4) and reverse signaling (EphB4-to-EFNB2 via the intracellular tail, with aa 313–331 critical for VSMC contractility); it functions in arterial identity and angiogenesis, regulates vascular smooth muscle cell contractility and blood pressure, controls T cell development and IL-6/STAT3 signaling, promotes assembly of Cx30 gap junction plaques in cochlear cells via Eph receptor-independent reverse signaling, mediates tracheoesophageal separation through NKX2-1-dependent transcriptional repression, supports neurovascular regeneration in skeletal muscle via endothelial cell expression, and acts downstream of ITGA5/mTORC1 and upstream of p53/p21 and PI3K/AKT pathways in various cancer contexts."},"narrative":{"mechanistic_narrative":"EFNB2 (ephrin-B2) is a membrane-bound ligand for EPH-related receptor tyrosine kinases that engages in trans with EPHB4 to drive bi-directional signaling controlling vascular patterning, contractility, and tissue morphogenesis [PMID:8559144, PMID:27530629, PMID:31949258]. Binding induces forward (EFNB2-to-EphB4) receptor phosphorylation [PMID:8559144], while reverse signaling through the EFNB2 intracellular tail — with residues 313–331 essential for vascular smooth muscle cell contractility — regulates blood pressure, with EPHB4 identified by crosslinking as the critical forward-signaling receptor in this context [PMID:27530629]. The EFNB2/EphB4 axis exerts opposing effects on tumor biology: forward signaling suppresses tumor cell proliferation whereas reverse signaling stimulates endothelial invasion and angiogenesis [PMID:31949258]. EFNB2 is positioned downstream of Notch-dependent arterial specification programs, where sox7/Notch/hey2 act upstream of efnb2 and NOTCH4 positively regulates EFNB2 expression in endothelial progenitors [PMID:25834021, PMID:27069008]. In development, NKX2-1 directly represses Efnb2 transcription to control dorsoventral cell sorting during tracheoesophageal separation [PMID:35294885], and endothelial EFNB2 supports capillary regeneration and neuromuscular junction recovery after skeletal muscle injury [PMID:39196901]. Beyond vasculature, EFNB2 controls T-cell development and IL-6/STAT3-dependent differentiation and chemotaxis [PMID:21976681, PMID:22673212, PMID:25779027], promotes assembly of connexin-30 gap junction plaques in cochlear cells via an Eph receptor-independent reverse-signaling mechanism [PMID:34139316], and acts as a downstream effector in multiple cancer pathways including STAT3/LDLR-mediated cholesterol uptake and mTORC1-ITGA5 signaling [PMID:36376513, PMID:36438491]. EFNB2 expression is post-transcriptionally restrained by miR-137 and miR-193a-3p targeting of its 3'-UTR [PMID:27650867, PMID:33585562].","teleology":[{"year":1995,"claim":"Established EFNB2 as a functional ligand, answering whether the protein actively engages EPH-family receptors rather than merely binding them.","evidence":"cDNA isolation with in vitro receptor binding and phosphorylation assays for ELK and HEK receptors","pmids":["8559144"],"confidence":"Medium","gaps":["Did not identify EPHB4 as the physiological receptor","No cellular or in vivo signaling context defined","Reverse signaling not addressed"]},{"year":2008,"claim":"Linked EFNB2/EPHB4 expression dynamics to arterial versus venous identity in vivo, addressing how positional sorting of vascular cells is specified.","evidence":"Immunohistochemistry time-course in normal and alymphoid mice with lymphocyte transfer rescue","pmids":["18463357"],"confidence":"Medium","gaps":["Association inferred from expression, not signaling perturbation","Direct molecular driver of cell positioning untested"]},{"year":2011,"claim":"Showed EFNB2 (with EFNB1) is required for IL-6/STAT3 signaling in T cells, revealing a role outside classical Eph-receptor vascular signaling.","evidence":"T cell-specific conditional double knockout mice with STAT3 phosphorylation and differentiation assays","pmids":["21976681"],"confidence":"Medium","gaps":["Redundancy with EFNB1 obscures EFNB2-specific contribution","Biochemical link between EFNB2 and STAT3 not resolved"]},{"year":2012,"claim":"Defined the limits of EFNB2's non-redundant role in T cell development, distinguishing essential from redundant functions.","evidence":"T cell-specific single EFNB2 knockout mice with flow cytometry and differentiation/activation assays","pmids":["22673212"],"confidence":"Medium","gaps":["Single-gene phenotype mild due to family redundancy","Mechanism of DN3 thymocyte accumulation unknown"]},{"year":2015,"claim":"Mapped EFNB2 intracellular tail function to T cell chemotaxis and placed efnb2 downstream of sox7/Notch in arterial development.","evidence":"Intracellular tail deletion mutagenesis with chemotaxis/migration assays in mice; zebrafish genetic epistasis with NICD rescue","pmids":["25779027","25834021"],"confidence":"Medium","gaps":["Reverse-signaling effectors downstream of the tail unidentified","Direct vs indirect Notch-efnb2 link not biochemically resolved"]},{"year":2016,"claim":"Identified EPHB4 as the critical forward-signaling receptor and mapped the reverse-signaling domain (aa 313–331) controlling vascular smooth muscle contractility and blood pressure.","evidence":"Smooth muscle-specific conditional KO, crosslinking receptor identification, tail deletion mutagenesis, blood pressure and contractility assays; comparative NOTCH4/NOTCH1 knockdown in EPCs","pmids":["27530629","27069008"],"confidence":"High","gaps":["Downstream contractile effectors of reverse signaling not defined","Sex-specific blood pressure effect mechanism unclear"]},{"year":2016,"claim":"Established post-transcriptional control of EFNB2 by miR-137 and a 3'-UTR variant, revealing a regulatory layer on EFNB2 abundance.","evidence":"Luciferase reporter assays with wild-type and mutant 3'-UTR constructs, RT-qPCR, western blot","pmids":["27650867"],"confidence":"Medium","gaps":["Physiological context where miR-137 regulates EFNB2 not defined","Phenotypic consequence of the SNP untested in vivo"]},{"year":2020,"claim":"Demonstrated opposing forward versus reverse signaling outputs in tumor biology and provided a pharmacological tool to bias the axis therapeutically.","evidence":"BIDEN-AP agonist peptide design, in vitro invasion/migration/tube formation, orthotopic tumor model; EFNB2 knockdown in PDAC with p53/p21 cell cycle and EMT readouts","pmids":["31949258","32036221"],"confidence":"Medium","gaps":["Direct biochemical link from EFNB2 to p53/p21 not shown","Cell-type specificity of forward vs reverse effects incompletely mapped"]},{"year":2021,"claim":"Revealed an Eph receptor-independent reverse-signaling role for EFNB2 in organizing Cx30 gap junction plaques, broadening the mechanistic repertoire.","evidence":"In situ proximity ligation assay, heterozygous Efnb2 null mice, clathrin internalization and organotypic reverse-signaling activation assays","pmids":["34139316"],"confidence":"Medium","gaps":["Molecular machinery linking reverse signaling to clathrin internalization unknown","Direct Cx30 binding partner of EFNB2 unresolved"]},{"year":2022,"claim":"Established direct transcriptional repression of Efnb2 by NKX2-1 and its role in cell-sorting-driven tracheoesophageal separation.","evidence":"ChIP, reporter assays, conditional knockout, lineage tracing, and mosaic NKX2-1 loss-of-function in mice","pmids":["35294885"],"confidence":"High","gaps":["Eph receptor mediating tracheal cell sorting not identified","Quantitative threshold of EFNB2 required for boundary formation unknown"]},{"year":2022,"claim":"Positioned the EFNB2/EPHB4 axis within cancer metabolic and growth signaling, linking it to STAT3/LDLR cholesterol uptake and mTORC1-ITGA5 regulation.","evidence":"In vitro/in vivo CRC liver metastasis models with STAT3 and LDLR assays; Raptor knockdown, transcriptomics, and xenografts in LSCC","pmids":["36376513","36438491"],"confidence":"Medium","gaps":["Whether EFNB2 acts via forward or reverse signaling in these contexts not dissected","Direct physical interactions upstream/downstream not all validated"]},{"year":2024,"claim":"Defined endothelial EFNB2 as required for capillary and neuromuscular junction regeneration after muscle injury, establishing a tissue-repair role.","evidence":"Inducible endothelial-specific conditional KO, BaCl2 injury, isometric force, NMJ morphology and transmission assays","pmids":["39196901"],"confidence":"High","gaps":["Signaling partner mediating regenerative effect unidentified","Link between capillary and NMJ defects mechanistically unresolved"]},{"year":2024,"claim":"Extended EFNB2 signaling to additional contexts: PI3K/AKT-dependent anti-apoptotic effects, RSV host-factor activity, EPHB2-mediated tumor circadian/metabolic reprogramming, and trophoblast EMT regulation.","evidence":"Pathway inhibitor studies in NP cells; gain/loss of function in RSV cell lines; TAM-tumor co-culture and in vivo models; miR-193a-3p luciferase and Transwell assays","pmids":["38636690","26277777","39298082","33585562"],"confidence":"Medium","gaps":["Directionality (forward/reverse) of signaling not resolved in several contexts","Direct EFNB2 molecular interactions in RSV replication unknown"]},{"year":null,"claim":"How EFNB2 reverse-signaling outputs are mechanistically transduced — the intracellular effectors engaged by the cytoplasmic tail across vascular, cochlear, and developmental contexts — remains undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No identified intracellular signaling complex downstream of the EFNB2 tail","Receptor-independent reverse-signaling mechanism unresolved","Structural basis of context-specific forward vs reverse output unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,4,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,8,10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,11,16]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,9,12,13]}],"complexes":[],"partners":["EPHB4","EPHB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P52799","full_name":"Ephrin-B2","aliases":["EPH-related receptor tyrosine kinase ligand 5","LERK-5","HTK ligand","HTK-L"],"length_aa":333,"mass_kda":36.9,"function":"Cell surface transmembrane ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds to receptor tyrosine kinase including EPHA4, EPHA3 and EPHB4. Together with EPHB4 plays a central role in heart morphogenesis and angiogenesis through regulation of cell adhesion and cell migration. EPHB4-mediated forward signaling controls cellular repulsion and segregation from EFNB2-expressing cells. May play a role in constraining the orientation of longitudinally projecting axons (Microbial infection) Acts as a receptor for Hendra virus and Nipah virus","subcellular_location":"Cell membrane; Cell junction, adherens junction","url":"https://www.uniprot.org/uniprotkb/P52799/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/EFNB2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/EFNB2","total_profiled":1310},"omim":[{"mim_id":"615759","title":"KINASE D-INTERACTING SUBSTRATE, 220-KD; KIDINS220","url":"https://www.omim.org/entry/615759"},{"mim_id":"611559","title":"UROPLAKIN 3A; UPK3A","url":"https://www.omim.org/entry/611559"},{"mim_id":"611123","title":"EPHRIN RECEPTOR EphA10; EPHA10","url":"https://www.omim.org/entry/611123"},{"mim_id":"611052","title":"SET DOMAIN-CONTAINING PROTEIN 1A; SETD1A","url":"https://www.omim.org/entry/611052"},{"mim_id":"608677","title":"MIB E3 UBIQUITIN PROTEIN LIGASE 1; MIB1","url":"https://www.omim.org/entry/608677"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EFNB2"},"hgnc":{"alias_symbol":["LERK5","Htk-L","HTKL","MGC126226","MGC126227","MGC126228"],"prev_symbol":["EPLG5"]},"alphafold":{"accession":"P52799","domains":[{"cath_id":"2.60.40.420","chopping":"32-163","consensus_level":"high","plddt":93.2436,"start":32,"end":163}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P52799","model_url":"https://alphafold.ebi.ac.uk/files/AF-P52799-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P52799-F1-predicted_aligned_error_v6.png","plddt_mean":70.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EFNB2","jax_strain_url":"https://www.jax.org/strain/search?query=EFNB2"},"sequence":{"accession":"P52799","fasta_url":"https://rest.uniprot.org/uniprotkb/P52799.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P52799/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P52799"}},"corpus_meta":[{"pmid":"10984508","id":"PMC_10984508","title":"Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10984508","citation_count":86,"is_preprint":false},{"pmid":"10389937","id":"PMC_10389937","title":"High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.","date":"1999","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/10389937","citation_count":74,"is_preprint":false},{"pmid":"31574534","id":"PMC_31574534","title":"Induced Expression of VEGFC, ANGPT, and EFNB2 and Their Receptors Characterizes Neovascularization in Proliferative Diabetic Retinopathy.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31574534","citation_count":53,"is_preprint":false},{"pmid":"21976681","id":"PMC_21976681","title":"Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21976681","citation_count":50,"is_preprint":false},{"pmid":"8559144","id":"PMC_8559144","title":"Isolation of LERK-5: a ligand of the eph-related receptor tyrosine kinases.","date":"1995","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8559144","citation_count":49,"is_preprint":false},{"pmid":"27650867","id":"PMC_27650867","title":"MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients.","date":"2016","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/27650867","citation_count":47,"is_preprint":false},{"pmid":"25834021","id":"PMC_25834021","title":"Sox7 controls arterial specification in conjunction with hey2 and efnb2 function.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25834021","citation_count":44,"is_preprint":false},{"pmid":"32036221","id":"PMC_32036221","title":"EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32036221","citation_count":39,"is_preprint":false},{"pmid":"18463357","id":"PMC_18463357","title":"Dynamic changes occur in patterns of endometrial EFNB2/EPHB4 expression during the period of spiral arterial modification in mice.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18463357","citation_count":34,"is_preprint":false},{"pmid":"36438491","id":"PMC_36438491","title":"Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/36438491","citation_count":32,"is_preprint":false},{"pmid":"24038947","id":"PMC_24038947","title":"De novo 13q deletions in two patients with mild anorectal malformations as part of VATER/VACTERL and VATER/VACTERL-like association and analysis of EFNB2 in patients with anorectal malformations.","date":"2013","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24038947","citation_count":32,"is_preprint":false},{"pmid":"17476318","id":"PMC_17476318","title":"Mutational analyses of UPIIIA, SHH, EFNB2 and HNF1beta in persistent cloaca and associated kidney malformations.","date":"2007","source":"Journal of pediatric urology","url":"https://pubmed.ncbi.nlm.nih.gov/17476318","citation_count":24,"is_preprint":false},{"pmid":"36376513","id":"PMC_36376513","title":"Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36376513","citation_count":22,"is_preprint":false},{"pmid":"29508392","id":"PMC_29508392","title":"EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder.","date":"2018","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29508392","citation_count":22,"is_preprint":false},{"pmid":"25779027","id":"PMC_25779027","title":"Role of EFNB1 and EFNB2 in Mouse Collagen-Induced Arthritis and Human Rheumatoid Arthritis.","date":"2015","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25779027","citation_count":19,"is_preprint":false},{"pmid":"27530629","id":"PMC_27530629","title":"Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk.","date":"2016","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/27530629","citation_count":16,"is_preprint":false},{"pmid":"20483485","id":"PMC_20483485","title":"Is the EFNB2 locus associated with schizophrenia? Single nucleotide polymorphisms and haplotypes analysis.","date":"2010","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/20483485","citation_count":15,"is_preprint":false},{"pmid":"27069008","id":"PMC_27069008","title":"NOTCH4 signaling controls EFNB2-induced endothelial progenitor cell dysfunction in preeclampsia.","date":"2016","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27069008","citation_count":14,"is_preprint":false},{"pmid":"31949258","id":"PMC_31949258","title":"Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31949258","citation_count":12,"is_preprint":false},{"pmid":"22673212","id":"PMC_22673212","title":"T cell-specific deletion of EFNB2 minimally affects T cell development and function.","date":"2012","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22673212","citation_count":12,"is_preprint":false},{"pmid":"12773430","id":"PMC_12773430","title":"Increased messenger RNA for allograft inflammatory factor-1, LERK-5, and a novel gene in 17.5-day relative to 15.5-day bovine embryos.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12773430","citation_count":12,"is_preprint":false},{"pmid":"35294885","id":"PMC_35294885","title":"Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35294885","citation_count":11,"is_preprint":false},{"pmid":"26501487","id":"PMC_26501487","title":"Role of EFNB2/EPHB4 signaling in spiral artery development during pregnancy: An appraisal.","date":"2015","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/26501487","citation_count":9,"is_preprint":false},{"pmid":"34139316","id":"PMC_34139316","title":"Efnb2 haploinsufficiency induces early gap junction plaque disassembly and endocytosis in the cochlea.","date":"2021","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/34139316","citation_count":9,"is_preprint":false},{"pmid":"30106123","id":"PMC_30106123","title":"Upregulated EFNB2 and EPHB4 promotes lung development in a nitrofen-induced congenital diaphragmatic hernia rat model.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30106123","citation_count":9,"is_preprint":false},{"pmid":"26277777","id":"PMC_26277777","title":"Identification of CCL2, RARRES2 and EFNB2 as host cell factors that influence the multistep replication of respiratory syncytial virus.","date":"2015","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/26277777","citation_count":7,"is_preprint":false},{"pmid":"37636764","id":"PMC_37636764","title":"Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer.","date":"2023","source":"Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","url":"https://pubmed.ncbi.nlm.nih.gov/37636764","citation_count":5,"is_preprint":false},{"pmid":"38636690","id":"PMC_38636690","title":"Ephrin B2 (EFNB2) potentially protects against intervertebral disc degeneration through inhibiting nucleus pulposus cell apoptosis.","date":"2024","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/38636690","citation_count":5,"is_preprint":false},{"pmid":"39196901","id":"PMC_39196901","title":"Inducible deletion of endothelial cell Efnb2 delays capillary regeneration and attenuates myofibre reinnervation following myotoxin injury in mice.","date":"2024","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/39196901","citation_count":4,"is_preprint":false},{"pmid":"39298082","id":"PMC_39298082","title":"Circadian system disorder induced by aberrantly activated EFNB2-EPHB2 axis leads to facilitated liver metastasis in gastric cancer.","date":"2024","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/39298082","citation_count":4,"is_preprint":false},{"pmid":"33585562","id":"PMC_33585562","title":"miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/33585562","citation_count":4,"is_preprint":false},{"pmid":"21735541","id":"PMC_21735541","title":"Generation of transgenic mice overexpressing EfnB2 in endothelial cells.","date":"2011","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/21735541","citation_count":3,"is_preprint":false},{"pmid":"37111257","id":"PMC_37111257","title":"The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease.","date":"2023","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37111257","citation_count":2,"is_preprint":false},{"pmid":"40045230","id":"PMC_40045230","title":"Exploring the causal relationship between serum EFNB2 levels and epilepsy: a bidirectional Mendelian randomization and co-localization analysis.","date":"2025","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/40045230","citation_count":1,"is_preprint":false},{"pmid":"33611045","id":"PMC_33611045","title":"Generation of an EFNB2-2A-mCherry reporter human embryonic stem cell line using CRISPR/Cas9-mediated site-specific homologous recombination.","date":"2021","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33611045","citation_count":0,"is_preprint":false},{"pmid":"37461443","id":"PMC_37461443","title":"A long non-coding RNA Leat1 mediates the hormone responsiveness of EfnB2 during male urogenital development.","date":"2023","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/37461443","citation_count":0,"is_preprint":false},{"pmid":"41398470","id":"PMC_41398470","title":"A long non-coding RNA Leat1 mediates the hormone responsiveness of EfnB2 during male urogenital development.","date":"2025","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41398470","citation_count":0,"is_preprint":false},{"pmid":"38965134","id":"PMC_38965134","title":"LncRNA BBOX1-AS1 Contributes to Laryngeal Carcinoma Progression by Recruiting SRSF1 to Maintain EFNB2 mRNA Stability.","date":"2024","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38965134","citation_count":0,"is_preprint":false},{"pmid":"42159828","id":"PMC_42159828","title":"Mild hypothermia inhibits the inflammatory response and microglial M1 polarization in ischemic stroke via the EFNB2/EphB4 pathway.","date":"2026","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/42159828","citation_count":0,"is_preprint":false},{"pmid":"35242814","id":"PMC_35242814","title":"Corrigendum: miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/35242814","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.03.25330832","title":"Etiological basis for chronic pain genetic variation in brain and dorsal root ganglia cell types","date":"2025-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.03.25330832","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.08.24318691","title":"Macrophage ferroptosis potentiates GCN2 deficiency induced pulmonary venous arterialization","date":"2025-02-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.08.24318691","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.18.608498","title":"Loss of Zmiz1 in mice leads to impaired cortical development and autistic-like behaviors","date":"2024-08-18","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.18.608498","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.25.622742","title":"Arterial endothelial deletion of hereditary hemorrhagic telangiectasia 2/  <i>Alk1</i>  causes epistaxis and cerebral microhemorrhage with aberrant arteries and defective smooth muscle coverage","date":"2024-11-28","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.25.622742","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.15.603563","title":"EPHA1 and EPHB4 tyrosine kinase receptors regulate epithelial morphogenesis","date":"2024-07-16","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.15.603563","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.21.604518","title":"Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC","date":"2024-07-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.21.604518","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25762,"output_tokens":6191,"usd":0.085075,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14892,"output_tokens":4235,"usd":0.090167,"stage2_stop_reason":"end_turn"},"total_usd":0.175242,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"EFNB2 (LERK-5) was identified as a membrane-bound ligand for both ELK and HEK (EPH-related receptor tyrosine kinases) and induces receptor phosphorylation upon binding.\",\n      \"method\": \"cDNA isolation, receptor binding assay, receptor phosphorylation assay in vitro\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct receptor phosphorylation assay with identified binding partners, single lab but two orthogonal methods (binding + phosphorylation)\",\n      \"pmids\": [\"8559144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"T cell-specific double knockout of Efnb1 and Efnb2 in mice compromised IL-6 signaling, specifically abolishing STAT3 phosphorylation upon IL-6 stimulation, contributing to defects in Th1/Th17 differentiation and antiviral immune response.\",\n      \"method\": \"Conditional knockout mice (loxP-mediated), flow cytometry, in vitro T cell differentiation assays, STAT3 phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean conditional KO with defined cellular phenotype and biochemical pathway readout (STAT3 phosphorylation), single lab\",\n      \"pmids\": [\"21976681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"T cell-specific single knockout of EFNB2 alone causes a moderate increase in DN3 thymocyte subpopulation and CD4CD8 double-negative cells, but does not broadly impair T cell activation, proliferation, or Th1/Th2/Th17/Treg differentiation, indicating functional redundancy within the Eph/ephrin family.\",\n      \"method\": \"Conditional knockout mice, flow cytometry, competitive repopulation chimeras, in vitro T cell differentiation and activation assays\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean conditional KO with multiple cellular readouts, single lab\",\n      \"pmids\": [\"22673212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In T cells, deletion of the intracellular tails of Efnb1 and Efnb2 revealed critical regions controlling T cell chemotaxis toward CXCL12; Efnb1/Efnb2-deficient T cells showed reduced migration to arthritic paws in vivo and impaired chemotaxis in vitro, and provided inferior B cell help for collagen-specific antibody production.\",\n      \"method\": \"Conditional double knockout mice (CIA model), deletion mutagenesis of intracellular tail, in vitro chemotaxis assay, in vivo migration assay, B cell help assay\",\n      \"journal\": \"Arthritis & rheumatology (Hoboken, N.J.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion mutagenesis combined with in vivo and in vitro functional assays, single lab\",\n      \"pmids\": [\"25779027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Smooth muscle cell-specific deletion of EFNB2 in male mice reduced blood pressure. Both forward (EFNB2-to-EPH) and reverse (EPH-to-EFNB2) signaling regulate vascular smooth muscle cell contractility; EPHB4 was identified as the critical receptor for forward signaling by crosslinking studies, and a region from aa 313 to aa 331 in the EFNB2 intracellular tail was essential for reverse signaling regulating VSMC contractility.\",\n      \"method\": \"Smooth muscle cell-specific conditional knockout mice, blood pressure measurement, crosslinking studies, intracellular tail deletion mutagenesis, VSMC contractility assays\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — conditional KO, crosslinking to identify receptor, deletion mutagenesis to map functional domain, multiple orthogonal methods in one study\",\n      \"pmids\": [\"27530629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In mouse endometrium, uNK cells express EFNB2 early in gestation then transition to EPHB4 expression; spiral arteries shift from EFNB2+/EPHB4- to EFNB2+/EPHB4+, and expression of EFNB2 by uNK cells and trophoblasts is proposed as the mechanism driving their positional association with EFNB2+ arteries and exclusion from EPHB4+ veins. Gain of EPHB4 by midgestation spiral arteries may signal completion of arterial modification.\",\n      \"method\": \"Immunohistochemistry time-course in normal and uNK cell-deficient (alymphoid) mice, lymphocyte transfer rescue experiments\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by IHC with functional consequence assessed by genetic (alymphoid) model and rescue, single lab\",\n      \"pmids\": [\"18463357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In zebrafish, genetic interaction studies showed that sox7 acts upstream of Notch (with hey2 and efnb2) in arterial specification; loss of sox7, hey2, or efnb2 each produce similar aberrant arteriovenous shunts, and overexpression of Notch intracellular domain rescues the sox7 mutant phenotype, placing sox7 upstream of Notch/hey2/efnb2 in arterial development.\",\n      \"method\": \"Zebrafish mutant generation, in vivo imaging, genetic epistasis (NICD overexpression rescue), in situ hybridization, transgenic reporter lines\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with rescue experiment, multiple mutants and orthogonal methods, single lab\",\n      \"pmids\": [\"25834021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NOTCH4 (not NOTCH1) is the specific receptor for the DLL4/NOTCH-EFNB2 cascade in endothelial progenitor cells; NOTCH4 downregulation decreased EFNB2 expression, while NOTCH1 silencing increased EFNB2 expression, demonstrating that NOTCH4 positively regulates EFNB2 expression in this context.\",\n      \"method\": \"siRNA knockdown of NOTCH4 vs NOTCH1 in EPCs, DLL4 stimulation, western blot, functional EPC assays\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — comparative knockdown of two receptors with biochemical and functional readouts, single lab\",\n      \"pmids\": [\"27069008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Trans-interaction between EphB4 and EFNB2 mediates bi-directional signaling: forward EFNB2-to-EphB4 signaling suppresses tumor cell proliferation, while reverse EphB4-to-EFNB2 signaling stimulates invasive and angiogenic properties of endothelial cells; a dual-function agonist peptide (BIDEN-AP) that engages EphB4 suppressed invasion, EMT, and endothelial migration in vitro and reduced orthotopic tumor growth in vivo.\",\n      \"method\": \"Peptide agonist design, in vitro invasion/migration/tube formation assays, in vivo orthotopic tumor model, receptor-mediated endocytosis assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vitro and in vivo functional assays demonstrating bi-directional signaling, single lab\",\n      \"pmids\": [\"31949258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Knockdown of EFNB2 in pancreatic ductal adenocarcinoma cells inhibited cell proliferation by upregulating p53/p21-mediated G0/G1 phase cell cycle arrest, and decreased migration and invasion by blocking epithelial-mesenchymal transition.\",\n      \"method\": \"siRNA knockdown in PDAC cell lines, cell cycle analysis, in vitro migration/invasion assays, western blot, in vivo xenograft\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined molecular pathway (p53/p21) and multiple cellular phenotype readouts, single lab\",\n      \"pmids\": [\"32036221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Ephrin-B2 promotes assembly of connexin 30 (Cx30) gap junction plaques between cochlear Deiters' cells; in situ proximity ligation assay showed ephrin-B2 preferentially interacts with Cx30 at the periphery of gap junction plaques. Efnb2 haploinsufficiency causes excessive clathrin-mediated internalization of Cx30 plaques in early postnatal stages. Ectopic activation of ephrin-B2 reverse signaling promotes Cx30 gap junction plaque internalization, suggesting a cell-autonomous, Eph receptor-independent role.\",\n      \"method\": \"In situ proximity ligation assay, heterozygous Efnb2 null mice, clathrin internalization assay, in vitro organotypic assay with ephrin-B2 reverse signaling activation\",\n      \"journal\": \"Brain research bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proximity ligation assay identifies Cx30 interaction, haploinsufficiency model with in vitro organotypic validation, single lab\",\n      \"pmids\": [\"34139316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NKX2-1 directly represses Efnb2 transcription in tracheal cells (demonstrated by chromatin immunoprecipitation and reporter assays); Efnb2 regulates tracheoesophageal separation by controlling dorsoventral allocation of tracheal-fated cells, and ectopic NKX2-1/EPHRIN-B2 boundaries organize ectopic tracheal separation via cell sorting.\",\n      \"method\": \"Conditional knockout mice, chromatin immunoprecipitation (ChIP), reporter assays, lineage tracing, mosaic NKX2-1 loss-of-function\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP and reporter assays establish direct transcriptional repression; lineage tracing and genetic mosaic provide mechanistic pathway placement; multiple orthogonal methods\",\n      \"pmids\": [\"35294885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The EFNB2/EPHB4 axis in colorectal cancer liver metastases promotes LDLR-mediated cholesterol uptake by activating STAT3 phosphorylation, which enhances LDLR transcription; blocking LDLR reversed the tumor-promoting role of the EFNB2/EPHB4 axis.\",\n      \"method\": \"In vitro cell line studies, in vivo mouse model, STAT3 phosphorylation assay, LDLR transcription assay, blocking experiments\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissection with rescue (LDLR blocking), multiple in vitro and in vivo methods, single lab\",\n      \"pmids\": [\"36376513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ITGA5 (integrin subunit alpha 5), acting as a downstream effector of mTORC1, promotes laryngeal squamous cell carcinoma progression through upregulation of EFNB2, defining an mTORC1-ITGA5-EFNB2 signaling axis.\",\n      \"method\": \"Stable Raptor knockdown, transcriptomic sequencing, western blot, immunofluorescence, xenograft models (CDX and PDX)\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway established using stable KD of upstream component, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"36438491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EFNB2 expression in MDCK cells (which have low RSV susceptibility) increased RSV replication 10-100 fold; siRNA knockdown of EFNB2 in RSV-susceptible cell lines (HEp-2 and A549) reduced RSV replication, establishing EFNB2 as a positive host factor for RSV replication.\",\n      \"method\": \"cDNA library transfection into MDCK cells, microarray analysis, siRNA knockdown, viral replication assays\",\n      \"journal\": \"Virus research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function and loss-of-function experiments in multiple cell lines converge on same conclusion, single lab\",\n      \"pmids\": [\"26277777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EFNB2 overexpression in nucleus pulposus cells activated the PI3K/AKT signaling pathway (increased phosphorylation of PI3K, AKT, and mTOR) and inhibited ERK1/2 phosphorylation, thereby reducing apoptosis; these anti-apoptotic effects were partially reversed by PI3K inhibitor LY294002 and ERK activator Ceramide C6 respectively.\",\n      \"method\": \"EFNB2 overexpression and knockdown in NP cells, PI3K inhibitor (LY294002) and ERK activator treatment, western blot for pathway components, apoptosis assays\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissection with pharmacological inhibitors confirming PI3K/AKT and ERK mechanisms, single lab\",\n      \"pmids\": [\"38636690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Endothelial cell-specific conditional knockout of Efnb2 in adult mice delayed capillary regeneration after acute skeletal muscle injury (reduced capillary area at 5 days post-injury) and attenuated recovery of neuromuscular junction structure and function (neuromuscular transmission failure with perturbed pre- and postsynaptic NMJ morphology).\",\n      \"method\": \"Inducible endothelial cell-specific conditional knockout (tamoxifen), BaCl2 muscle injury model, intravascular staining, isometric force measurement, nerve vs. direct stimulation, NMJ morphology analysis\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible cell-type-specific KO with multiple orthogonal functional readouts (capillary area, isometric force, NMJ morphology, neuromuscular transmission), rigorous controls\",\n      \"pmids\": [\"39196901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"miR-137 directly targets the 3'-UTR of EFNB2 mRNA and suppresses EFNB2 expression; a genetic variant SNP rs550067317 in the putative seed-pair region of the EFNB2 3'-UTR reverses the repressive effect of miR-137 on EFNB2.\",\n      \"method\": \"Luciferase reporter assays with wild-type and point-mutant 3'-UTR constructs, RT-qPCR, western blot\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter with mutagenesis establishes direct miR-137 targeting of EFNB2 3'-UTR, supported by expression assays, single lab\",\n      \"pmids\": [\"27650867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In zebrafish and Caco-2 spheroid cultures, EFNB2 is compartmentalized to the basolateral domain of epithelial cells; EFNB2 is required for epithelial morphogenesis (spheroid organization) acting through its cognate receptor EPHB4, which randomizes mitotic spindle orientation when depleted. EFNB2 is the most abundantly expressed EPHB4 ligand in Caco-2 cells.\",\n      \"method\": \"siRNA/shRNA depletion in Caco-2 spheroids, immunofluorescence localization, mitotic spindle orientation analysis, receptor ligand expression profiling\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, depletion phenotype with localization data but limited mechanistic detail on EFNB2-specific contribution vs EPHB4\",\n      \"pmids\": [\"bio_10.1101_2024.07.15.603563\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-193a-3p directly targets EFNB2 (confirmed by luciferase activity assay); miR-193a-3p-mediated suppression of EFNB2 promotes EMT (increased N-cadherin, vimentin, MMP2, MMP9; decreased E-cadherin) and enhances trophoblast cell migration and invasion, contributing to placenta accreta spectrum.\",\n      \"method\": \"Luciferase reporter assay, miR-193a-3p overexpression/inhibition, siEFNB2, Transwell migration/invasion assay, western blot for EMT markers\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct target validation by luciferase assay plus functional rescue experiments, single lab\",\n      \"pmids\": [\"33585562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Exogenous EFNB2 supplementation stimulated pulmonary branching in fetal rat lung explants and decreased the activity of p38, JNK, ERK, and STAT signaling pathways in the context of congenital diaphragmatic hernia.\",\n      \"method\": \"Ex vivo fetal lung culture, EFNB2 protein supplementation, Western blot for signaling pathways, morphometric analysis of branching\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single treatment assay in explant culture, single lab, no mutagenesis or receptor identification\",\n      \"pmids\": [\"30106123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TAMs expressing EFNB2 interact with gastric cancer tumor cells expressing EPHB2 via forward downstream signaling, leading to circadian rhythm disorder (CRD) in tumor cells and enhancement of the Warburg effect in metastatic liver niches.\",\n      \"method\": \"Co-culture experiments, 3D cell culture, intrasplenic injection in vivo model, clodronate macrophage depletion, bone marrow transplantation, EPH inhibitor treatment, PDX model\",\n      \"journal\": \"Cellular oncology (Dordrecht, Netherlands)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vivo and in vitro methods identifying EFNB2-EPHB2 forward signaling as the mechanistic axis, single lab\",\n      \"pmids\": [\"39298082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In a preclinical HNSCC model, vascular EFNB2 knockout combined with radiation therapy enhanced anti-tumor immunity, reduced Treg accumulation, and decreased metastasis; EFNB2-Fc fusion protein targeting the EphB4-ephrinB2 axis reduced local tumor growth and distant metastasis.\",\n      \"method\": \"Vascular-specific EFNB2 knockout mouse model, radiation therapy combination, tumor microenvironment immune profiling, EFNB2-Fc and Fc-TNYL-RAW-GS peptide treatment, preclinical HNSCC models\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, functional phenotype in vascular-specific KO but limited biochemical mechanism for EFNB2 specifically\",\n      \"pmids\": [\"bio_10.1101_2024.07.21.604518\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Reactivation of the EFNB2 pathway by exogenous EFNB2 recombinant protein rescued dendritic outgrowth deficits in Zmiz1 mutant cortical neurons, placing EFNB2 as a downstream effector of the transcriptional regulator ZMIZ1 in cortical neuron development.\",\n      \"method\": \"Zmiz1 forebrain-specific conditional knockout mice, transcriptomic analysis, exogenous EFNB2 recombinant protein rescue experiment, dendritic morphology quantification\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, rescue experiment with recombinant protein, single lab, pathway placement inferred from transcriptomics + single rescue assay\",\n      \"pmids\": [\"bio_10.1101_2024.08.18.608498\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"EFNB2 (ephrin-B2) is a membrane-bound ligand for EPH receptor tyrosine kinases (particularly EPHB4) that mediates bi-directional signaling: forward signaling (EFNB2-to-EphB4) and reverse signaling (EphB4-to-EFNB2 via the intracellular tail, with aa 313–331 critical for VSMC contractility); it functions in arterial identity and angiogenesis, regulates vascular smooth muscle cell contractility and blood pressure, controls T cell development and IL-6/STAT3 signaling, promotes assembly of Cx30 gap junction plaques in cochlear cells via Eph receptor-independent reverse signaling, mediates tracheoesophageal separation through NKX2-1-dependent transcriptional repression, supports neurovascular regeneration in skeletal muscle via endothelial cell expression, and acts downstream of ITGA5/mTORC1 and upstream of p53/p21 and PI3K/AKT pathways in various cancer contexts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"EFNB2 (ephrin-B2) is a membrane-bound ligand for EPH-related receptor tyrosine kinases that engages in trans with EPHB4 to drive bi-directional signaling controlling vascular patterning, contractility, and tissue morphogenesis [#0, #4, #8]. Binding induces forward (EFNB2-to-EphB4) receptor phosphorylation [#0], while reverse signaling through the EFNB2 intracellular tail — with residues 313–331 essential for vascular smooth muscle cell contractility — regulates blood pressure, with EPHB4 identified by crosslinking as the critical forward-signaling receptor in this context [#4]. The EFNB2/EphB4 axis exerts opposing effects on tumor biology: forward signaling suppresses tumor cell proliferation whereas reverse signaling stimulates endothelial invasion and angiogenesis [#8]. EFNB2 is positioned downstream of Notch-dependent arterial specification programs, where sox7/Notch/hey2 act upstream of efnb2 and NOTCH4 positively regulates EFNB2 expression in endothelial progenitors [#6, #7]. In development, NKX2-1 directly represses Efnb2 transcription to control dorsoventral cell sorting during tracheoesophageal separation [#11], and endothelial EFNB2 supports capillary regeneration and neuromuscular junction recovery after skeletal muscle injury [#16]. Beyond vasculature, EFNB2 controls T-cell development and IL-6/STAT3-dependent differentiation and chemotaxis [#1, #2, #3], promotes assembly of connexin-30 gap junction plaques in cochlear cells via an Eph receptor-independent reverse-signaling mechanism [#10], and acts as a downstream effector in multiple cancer pathways including STAT3/LDLR-mediated cholesterol uptake and mTORC1-ITGA5 signaling [#12, #13]. EFNB2 expression is post-transcriptionally restrained by miR-137 and miR-193a-3p targeting of its 3'-UTR [#17, #19].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established EFNB2 as a functional ligand, answering whether the protein actively engages EPH-family receptors rather than merely binding them.\",\n      \"evidence\": \"cDNA isolation with in vitro receptor binding and phosphorylation assays for ELK and HEK receptors\",\n      \"pmids\": [\"8559144\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify EPHB4 as the physiological receptor\", \"No cellular or in vivo signaling context defined\", \"Reverse signaling not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linked EFNB2/EPHB4 expression dynamics to arterial versus venous identity in vivo, addressing how positional sorting of vascular cells is specified.\",\n      \"evidence\": \"Immunohistochemistry time-course in normal and alymphoid mice with lymphocyte transfer rescue\",\n      \"pmids\": [\"18463357\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Association inferred from expression, not signaling perturbation\", \"Direct molecular driver of cell positioning untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed EFNB2 (with EFNB1) is required for IL-6/STAT3 signaling in T cells, revealing a role outside classical Eph-receptor vascular signaling.\",\n      \"evidence\": \"T cell-specific conditional double knockout mice with STAT3 phosphorylation and differentiation assays\",\n      \"pmids\": [\"21976681\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Redundancy with EFNB1 obscures EFNB2-specific contribution\", \"Biochemical link between EFNB2 and STAT3 not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the limits of EFNB2's non-redundant role in T cell development, distinguishing essential from redundant functions.\",\n      \"evidence\": \"T cell-specific single EFNB2 knockout mice with flow cytometry and differentiation/activation assays\",\n      \"pmids\": [\"22673212\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-gene phenotype mild due to family redundancy\", \"Mechanism of DN3 thymocyte accumulation unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapped EFNB2 intracellular tail function to T cell chemotaxis and placed efnb2 downstream of sox7/Notch in arterial development.\",\n      \"evidence\": \"Intracellular tail deletion mutagenesis with chemotaxis/migration assays in mice; zebrafish genetic epistasis with NICD rescue\",\n      \"pmids\": [\"25779027\", \"25834021\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reverse-signaling effectors downstream of the tail unidentified\", \"Direct vs indirect Notch-efnb2 link not biochemically resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified EPHB4 as the critical forward-signaling receptor and mapped the reverse-signaling domain (aa 313–331) controlling vascular smooth muscle contractility and blood pressure.\",\n      \"evidence\": \"Smooth muscle-specific conditional KO, crosslinking receptor identification, tail deletion mutagenesis, blood pressure and contractility assays; comparative NOTCH4/NOTCH1 knockdown in EPCs\",\n      \"pmids\": [\"27530629\", \"27069008\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream contractile effectors of reverse signaling not defined\", \"Sex-specific blood pressure effect mechanism unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established post-transcriptional control of EFNB2 by miR-137 and a 3'-UTR variant, revealing a regulatory layer on EFNB2 abundance.\",\n      \"evidence\": \"Luciferase reporter assays with wild-type and mutant 3'-UTR constructs, RT-qPCR, western blot\",\n      \"pmids\": [\"27650867\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological context where miR-137 regulates EFNB2 not defined\", \"Phenotypic consequence of the SNP untested in vivo\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated opposing forward versus reverse signaling outputs in tumor biology and provided a pharmacological tool to bias the axis therapeutically.\",\n      \"evidence\": \"BIDEN-AP agonist peptide design, in vitro invasion/migration/tube formation, orthotopic tumor model; EFNB2 knockdown in PDAC with p53/p21 cell cycle and EMT readouts\",\n      \"pmids\": [\"31949258\", \"32036221\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical link from EFNB2 to p53/p21 not shown\", \"Cell-type specificity of forward vs reverse effects incompletely mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed an Eph receptor-independent reverse-signaling role for EFNB2 in organizing Cx30 gap junction plaques, broadening the mechanistic repertoire.\",\n      \"evidence\": \"In situ proximity ligation assay, heterozygous Efnb2 null mice, clathrin internalization and organotypic reverse-signaling activation assays\",\n      \"pmids\": [\"34139316\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular machinery linking reverse signaling to clathrin internalization unknown\", \"Direct Cx30 binding partner of EFNB2 unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established direct transcriptional repression of Efnb2 by NKX2-1 and its role in cell-sorting-driven tracheoesophageal separation.\",\n      \"evidence\": \"ChIP, reporter assays, conditional knockout, lineage tracing, and mosaic NKX2-1 loss-of-function in mice\",\n      \"pmids\": [\"35294885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Eph receptor mediating tracheal cell sorting not identified\", \"Quantitative threshold of EFNB2 required for boundary formation unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Positioned the EFNB2/EPHB4 axis within cancer metabolic and growth signaling, linking it to STAT3/LDLR cholesterol uptake and mTORC1-ITGA5 regulation.\",\n      \"evidence\": \"In vitro/in vivo CRC liver metastasis models with STAT3 and LDLR assays; Raptor knockdown, transcriptomics, and xenografts in LSCC\",\n      \"pmids\": [\"36376513\", \"36438491\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether EFNB2 acts via forward or reverse signaling in these contexts not dissected\", \"Direct physical interactions upstream/downstream not all validated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined endothelial EFNB2 as required for capillary and neuromuscular junction regeneration after muscle injury, establishing a tissue-repair role.\",\n      \"evidence\": \"Inducible endothelial-specific conditional KO, BaCl2 injury, isometric force, NMJ morphology and transmission assays\",\n      \"pmids\": [\"39196901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling partner mediating regenerative effect unidentified\", \"Link between capillary and NMJ defects mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended EFNB2 signaling to additional contexts: PI3K/AKT-dependent anti-apoptotic effects, RSV host-factor activity, EPHB2-mediated tumor circadian/metabolic reprogramming, and trophoblast EMT regulation.\",\n      \"evidence\": \"Pathway inhibitor studies in NP cells; gain/loss of function in RSV cell lines; TAM-tumor co-culture and in vivo models; miR-193a-3p luciferase and Transwell assays\",\n      \"pmids\": [\"38636690\", \"26277777\", \"39298082\", \"33585562\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Directionality (forward/reverse) of signaling not resolved in several contexts\", \"Direct EFNB2 molecular interactions in RSV replication unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How EFNB2 reverse-signaling outputs are mechanistically transduced — the intracellular effectors engaged by the cytoplasmic tail across vascular, cochlear, and developmental contexts — remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No identified intracellular signaling complex downstream of the EFNB2 tail\", \"Receptor-independent reverse-signaling mechanism unresolved\", \"Structural basis of context-specific forward vs reverse output unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 4, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 8, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 11, 16]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 9, 12, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"EPHB4\", \"EPHB2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}